logo-loader
viewGenedrive PLC

Genedrive PLC looking to have its coronavirus test available in around eight weeks

Genedrive PLC's (LON:GDR) David Budd tells Proactive London's Andrew Scott a clinically validated high throughput format for its coronavirus test could be available in approximately eight weeks.

Its 96 SARS-COV-2 test can determine whether someone is infected with coronavirus.

As the test is freeze dried, it requires no refrigeration and is easier to transport

Quick facts: Genedrive PLC

Price: 165 GBX

AIM:GDR
Market: AIM
Market Cap: £57.54 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Genedrive PLC named herein, including the promotion by the Company of Genedrive PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 heads lower as UK monthly borrowing hits record...

Headlines from the Proactive UK newsroom. The FTSE 100 headed lower going into the bank holiday weekend on concern over the spat between China and US over Hong Kong. The blue-chip index was 110 points lower at 5,904. UK monthly borrowing hit a record £62.1bn in April as the government...

2 days, 14 hours ago

2 min read